Skip to main content

 Related scientific articles (all)

Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey.

Authors : Pilotto S, Avancini A, Menis J, Sperduti I, Giaj Levra M, Berghmans T, Bironzo P, Brandão M, De Ruysscher D, Edwards J, Faivre-Finn C, Girard N, Greillier L, Hendriks L, Lantuejoul S, Mauer M, Novello S, OBrien M, Reck M, Reguart N, Remon J, von der Thüsen J, Dingemans AC, Besse B, Milella M
Year : 2022
Journal : Lung Cancer
Volume : 169
Pages : 94-101

Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study.

Authors : Gregory J, Tselikas L, Allimant C, De Baere T, Bargellini I, Bell J, Bilbao JI, Bouvier A, Chapiro J, Chiesa C, Decaens T, Denys A, Duran R, Edeline J, Garin E, Ghelfi J, Helmberger T, Irani F, Lam M, Lewandowski R, Liu D, Loffroy R, Madoff DC, Mastier C, Salem R, Sangro B, Sze D, Vilgrain V, Vouche M, Guiu B, Ronot M
Year : 2022
Journal : Eur J Nucl Med Mol Imaging

Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer.

Authors : Awada AH, Boni V, Moreno V, Aftimos P, Kahatt C, Luepke-Estefan XE, Siguero M, Fernandez-Teruel C, Cullell-Young M, Tabernero J
Year : 2022
Journal : ESMO Open
Volume : 7
Pages : 100651

Heterotopic ossification and severe COVID-19 infection.

Authors : Benkhaled S, Gomes da Silveira Cauduro C, Alexiou J, Jayankura M, Van Gestel D
Year : 2022
Journal : QJM
Volume : 115
Pages : 201-203

Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.

Authors : Casasnovas RO, Follows G, Zijlstra JM, Vermaat JSP, Kalakonda N, Choquet S, Neste EVD, Hill B, Thieblemont C, Cavallo F, la Cruz F, Kuruvilla J, Hamad N, Jaeger U, Caimi PF, Gurion R, Warzocha K, Bakhshi S, Sancho JM, Schuster M, Egyed M, Offner F, Vassilakopoulos TP, Samal P, Ku M, Ma X, Chamoun K, Shah J, Canales M, Maerevoet M, Shacham S, Kauffman MG, Goy A
Year : 2022
Journal : Clin Lymphoma Myeloma Leuk
Volume : 22
Pages : 24-33

Initiation of a new anti-cancer medical treatment in ICU: a retrospective study.

Authors : Chicoisneau M, Paesmans M, Ameye L, Sculier JP, Meert AP
Year : 2022
Journal : Acta Clin Belg
Volume : 77
Pages : 337-345

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

Authors : Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH
Year : 2022
Journal : Eur Heart J
Volume : 43
Pages : 4229-4361

Biomarkers and immunotherapy: where are we?

Authors : Langouo Fontsa M, Padonou F, Willard-Gallo K
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 579-586

Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report.

Authors : Manta R, Delbart W, Duran Derijckere I, Quiriny M, Demetter P, Flamen P, Karfis I
Year : 2022
Journal : Eur J Hybrid Imaging
Volume : 6
Pages : 8

Efficacy and Safety of Tranexamic Acid in Cancer Surgery. An Update of Clinical Findings and Ongoing Research.

Authors : Zec T, Di Napoli R, Fievez L, Ben Aziz M, Ottaiano A, Vittori A, Perri F, Cascella M
Year : 2022
Journal : J Multidiscip Healthc
Volume : 15
Pages : 1427-1444

Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer.

Authors : Khan SZ, Arecco L, Villarreal-Garza C, Sirohi B, Ponde NF, Habeeb B, Brandão M, Azim HA Jr, Chowdhury AR, Bozovic-Spasojevic I, Kovalenko I, Odhiambo A, Seid FU, Mutombo AB, Petracci F, Vidra R, Altuna SC, Petrova M, Kourie HR, Ozturk MA, Razeti MG, Lengyel CG, Talibova N, Mariamidze E, Sacardo KP, Duma N, Gyawali B, Trapani D, Tagliamento M, Lambertini M
Year : 2022
Journal : JCO Glob Oncol
Volume : 8
Pages : e2100153

Recommendations on the management of multiple myeloma in 2020.

Authors : Vekemans MC, Doyen C, Caers J, Wu K, Kentos A, Mineur P, Michaux L, Delforge M, Meuleman N
Year : 2022
Journal : Acta Clin Belg
Volume : 77
Pages : 445-461

Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial.

Authors : Felip E, Smit EF, Molina-Vila MA, Dafni U, Massuti B, Berghmans T, de Marinis F, Passiglia F, Dingemans AC, Cobo M, Viteri S, Britschgi C, Cuffe S, Provencio M, Merkelbach-Bruse S, Andriakopoulou C, Kammler R, Ruepp B, Roschitzki-Voser H, Peters S, Wolf J, Stahel R
Year : 2022
Journal : Lung Cancer
Volume : 172
Pages : 94-99

Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2.

Authors : Goel S, Tan AR, Rugo HS, Aftimos P, Beelen A, Zhang J, Yi JS, Malik R, OShaughnessy J
Year : 2022
Journal : Future Oncol
Volume : 18
Pages : 3701-3711

Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma.

Authors : Leupin N, Zinzani PL, Morschhauser F, Dalle S, Maerevoet M, Michot JM, Ribrag V, Offner F, Beylot-Barry M, Moins-Teisserenc H, Zwaenepoel K, de Winne K, Battistella M, Hultberg A, Gandini D, Moshir M, Jacobs J, Delahaye T, Khan A, Zabrocki P, Silence K, Van Rompaey L, Borg C, Motta G, Melle F, Calleri A, Pauwels P, de Haard H, Pileri S, Bagot M
Year : 2022
Journal : Cancer
Volume : 128
Pages : 1004-1014

Antimicrobial susceptibility testing determined by Alfred 60/AST (Alifax®) in a multi-sites lab: performance's evaluation and optimization of workflow.

Authors : Cupaiolo R, Cherkaoui S, Serrano G, Dauby N, Georgala A, Blumental S, Maillart E, Hites M, Hallin M, Martiny D
Year : 2022
Journal : J Microbiol Methods
Volume : 194
Pages : 106433

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

Authors : Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH
Year : 2022
Journal : Eur Heart J Cardiovasc Imaging
Volume : 23
Pages : e333-e465

Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice.

Authors : Delforge M, Vekemans MC, Depaus J, Meuleman N, Van de Velde A, Vande Broek I, Vandervennet S, Van Hoorenbeeck S, Moorkens E, Strens D, Diels J, Ghilotti F, Haefliger B, Dalhuisen S, Deraedt W, Anguille S
Year : 2022
Journal : Hemasphere
Volume : 6
Pages : e813

Molecular oncology: what is needed to speed access to innovative therapies in clinical research?

Authors : Gourari K, Awada A, Kotecki N
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 575-578

Qualitative evaluation of the role of RTTs IGRT specialists and their influence on treatment delivery.

Authors : Sousa F, Somoano M, Jourani Y, Van Gestel D
Year : 2022
Journal : Tech Innov Patient Support Radiat Oncol
Volume : 22
Pages : 9-15